These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 37226342)
1. SARS-CoV-2 in Mexico: An Association Among Geography, Comorbidities, and Vitamin D Deficiency. Salas A; Rodríguez MA; Hernandes M; Muñoz VM; Cano A; Marmolejo LG; Calixto M; Imbert JL Am J Health Behav; 2023 Apr; 47(2):269-279. PubMed ID: 37226342 [No Abstract] [Full Text] [Related]
2. Association of Food Intake Quality with Vitamin D in SARS-CoV-2 Positive Patients from Mexico: A Cross-Sectional Study. González-Estevez G; Turrubiates-Hernández FJ; Herrera-Jiménez LE; Sánchez-Zuno GA; Herrera-Godina MG; Muñoz-Valle JF Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299717 [TBL] [Abstract][Full Text] [Related]
3. Severe COVID-19 patients have severe vitamin D deficiency in Northeast Mexico. Rodríguez Vidales EP; Garza Carrillo D; Salinas Martínez AM; Robles Rodríguez OA; Montes de Oca Luna R; Treviño Garza C; Marroquín Escamilla AR; de la O-Cavazos ME Nutr Hosp; 2022 Mar; 39(2):393-397. PubMed ID: 35187940 [TBL] [Abstract][Full Text] [Related]
4. Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity? Ferrari D; Locatelli M; Briguglio M; Lombardi G Cell Biochem Funct; 2021 Jan; 39(1):35-47. PubMed ID: 33137851 [TBL] [Abstract][Full Text] [Related]
5. Autumn COVID-19 surge dates in Europe correlated to latitudes, not to temperature-humidity, pointing to vitamin D as contributing factor. Walrand S Sci Rep; 2021 Jan; 11(1):1981. PubMed ID: 33479261 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D in SARS-CoV-2 infection. Decyk A; Kobylińska M; Antosik K; Kurowska K Rocz Panstw Zakl Hig; 2022; 73(1):5-12. PubMed ID: 35322953 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 fatalities, latitude, sunlight, and vitamin D. Whittemore PB Am J Infect Control; 2020 Sep; 48(9):1042-1044. PubMed ID: 32599103 [TBL] [Abstract][Full Text] [Related]
8. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146 [TBL] [Abstract][Full Text] [Related]
9. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country. Alguwaihes AM; Sabico S; Hasanato R; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alyusuf EY; Alzahrani SH; Al-Daghri NM; Jammah AA Aging Clin Exp Res; 2021 May; 33(5):1415-1422. PubMed ID: 33788172 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. Carpagnano GE; Di Lecce V; Quaranta VN; Zito A; Buonamico E; Capozza E; Palumbo A; Di Gioia G; Valerio VN; Resta O J Endocrinol Invest; 2021 Apr; 44(4):765-771. PubMed ID: 32772324 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers. Lugg ST; Mackay WR; Faniyi AA; Faustini SE; Webster C; Duffy JE; Hewison M; Shields AM; Parekh D; Richter AG; Scott A; Thickett DR BMJ Open Respir Res; 2022 Sep; 9(1):. PubMed ID: 36167472 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: "Vitamin D Deficiency and Outcome of COVID-19 Patients". Brenner H; Schöttker B Nutrients; 2020 Nov; 12(12):. PubMed ID: 33260798 [TBL] [Abstract][Full Text] [Related]
13. The association between vitamin D status and COVID-19 in England: A cohort study using UK Biobank. Lin LY; Mulick A; Mathur R; Smeeth L; Warren-Gash C; Langan SM PLoS One; 2022; 17(6):e0269064. PubMed ID: 35666716 [TBL] [Abstract][Full Text] [Related]
14. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico. Domínguez-Ramírez L; Solis-Tejeda I; Ayon-Aguilar J; Mayoral-Ortiz A; Sosa-Jurado F; Pelayo R; Santos-López G; Cortes-Hernandez P Front Public Health; 2022; 10():1010256. PubMed ID: 36176536 [TBL] [Abstract][Full Text] [Related]
15. Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19). Sajadi MM; Habibzadeh P; Vintzileos A; Shokouhi S; Miralles-Wilhelm F; Amoroso A JAMA Netw Open; 2020 Jun; 3(6):e2011834. PubMed ID: 32525550 [TBL] [Abstract][Full Text] [Related]
16. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial. Jaun F; Boesing M; Lüthi-Corridori G; Abig K; Makhdoomi A; Bloch N; Lins C; Raess A; Grillmayr V; Haas P; Schuetz P; Gabutti L; Muser J; Leuppi-Taegtmeyer AB; Giezendanner S; Brändle M; Leuppi JD Trials; 2022 Feb; 23(1):114. PubMed ID: 35120577 [TBL] [Abstract][Full Text] [Related]
17. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. Dror AA; Morozov N; Daoud A; Namir Y; Yakir O; Shachar Y; Lifshitz M; Segal E; Fisher L; Mizrachi M; Eisenbach N; Rayan D; Gruber M; Bashkin A; Kaykov E; Barhoum M; Edelstein M; Sela E PLoS One; 2022; 17(2):e0263069. PubMed ID: 35113901 [TBL] [Abstract][Full Text] [Related]
18. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. Merzon E; Tworowski D; Gorohovski A; Vinker S; Golan Cohen A; Green I; Frenkel-Morgenstern M FEBS J; 2020 Sep; 287(17):3693-3702. PubMed ID: 32700398 [TBL] [Abstract][Full Text] [Related]
19. Deficiency of Vitamin D, a Major Risk Factor for SARS-CoV-2 Severity. Dumache R; Enache A; Cut T; Paul C; Mihailescu A; Ionescu A; Novacescu D; Marinescu A; Ciocan V; Muresan C; Voicu A Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254021 [TBL] [Abstract][Full Text] [Related]
20. Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection. Martinez-Fierro ML; Diaz-Lozano M; Alvarez-Zuñiga C; Ramirez-Hernandez LA; Araujo-Espino R; Trejo-Ortiz PM; Mollinedo-Montaño FE; Ortiz-Castro Y; Vazquez-Reyes S; Velasco-Elizondo P; Garcia-Esquivel L; Araujo-Conejo A; Garza-Veloz I Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917858 [No Abstract] [Full Text] [Related] [Next] [New Search]